Roth Capital Upgrades Medical Action (MDCI) to Buy
More News related to MDCI
- Roth Capital Upgrades Medical Action (MDCI) to Buy
- Emerging Stock Report Initiates Independent Research Coverage On Imaging3 Inc.
- Medical Action (MDCI) Posts Q2 EPS of $0.25, Tops by 4c
- Medical Action Industries Reports Strong Second Quarter 2010 Fiscal Results
- Trading Radar for 11/06: American International (AIG), Scripps (SNI), Suncor Energy (SU), Blackstone Group (BX) Report
More News related to Upgrades
- J. Crew (JCG) "Simply" Beats Q3 Earnings Views
- China Finance Online (JRJC) Tops Q3 EPS by 1c; Guides In-line for Q4 Revs
- Giant Interactive (GA) Tops Q3 Earnings Views
- Halliburton (HAL) Announced Major Reduction in Activity from Customer in Mexico; Sees Impact to Q4 Earnings
- Coldwater Creek (CWTR) Reports Mixed Q3 Results
Roth Capital upgrades Medical Action (Nasdaq: MDCI) from Hold to Buy. Price target increased from $13.50 to $15.
To see more analyst ratings on MDCI Click Here.
Medical Action Industries Inc. (Medical Action) develops, manufactures, markets and supplies a variety of disposable medical products.
Related Categories
UpgradesStocks Mentioned
+0.29Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
